{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:14:50Z","timestamp":1791231290420,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Arrhythmia and Electrophysiology"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:sec>\n            <jats:title>Background\u2014<\/jats:title>\n            <jats:p>In Multicenter Automatic Defibrillator Implantation Trial\u2013Cardiac Resynchronization Therapy (MADIT-CRT), patients with non\u2013left bundle branch block (LBBB; including right bundle branch block, intraventricular conduction delay) did not have clinical benefit from cardiac resynchronization therapy with defibrillator (CRT-D). We hypothesized that baseline PR interval modulates clinical response to CRT-D therapy in patients with non-LBBB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and Results\u2014<\/jats:title>\n            <jats:p>\n              Non-LBBB patients (n=537; 30%) were divided into 2 groups based on their baseline PR interval as normal (including minimally prolonged) PR (PR &lt;230 ms) and prolonged PR (PR \u2265230 ms). The primary end point was heart failure or death. Separate secondary end points included heart failure events and all-cause mortality. Cox proportional hazards regression models were used to compare risk of end point events by CRT-D to implantable cardioverter defibrillator therapy in the PR subgroups. There were 96 patients (22%) with a prolonged PR and 438 patients (78%) with a normal PR interval. In non-LBBB patients with a prolonged PR interval, CRT-D treatment was associated with a 73% reduction in the risk of heart failure\/death (hazard ratio, 0.27; 95% confidence interval, 0.13\u20130.57;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001) and 81% decrease in the risk of all-cause mortality (hazard ratio, 0.19; 95% confidence interval, 0.13\u20130.57;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001) compared with implantable cardioverter defibrillator therapy. In non-LBBB patients with normal PR, CRT-D therapy was associated with a trend toward an increased risk of heart failure\/death (hazard ratio, 1.45; 95% confidence interval, 0.96\u20132.19;\n              <jats:italic>P<\/jats:italic>\n              =0.078; interaction\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001) and a more than 2-fold higher mortality (hazard ratio, 2.14; 95% confidence interval, 1.12\u20134.09;\n              <jats:italic>P<\/jats:italic>\n              =0.022; interaction\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001) compared with implantable cardioverter defibrillator therapy.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions\u2014<\/jats:title>\n            <jats:p>The data support the use of CRT-D in MADIT-CRT non-LBBB patients with a prolonged PR interval. In non-LBBB patients with a normal PR interval, implantation of a CRT-D may be deleterious.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical Trial Registration\u2014<\/jats:title>\n            <jats:p>\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">http:\/\/clinicaltrials.gov<\/jats:ext-link>\n              ; Unique Identifier: NCT00180271.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circep.113.001299","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T05:27:05Z","timestamp":1403674025000},"page":"645-651","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":100,"title":["PR Interval Identifies Clinical Response in Patients With Non\u2013Left Bundle Branch Block"],"prefix":"10.1161","volume":"7","author":[{"given":"Valentina","family":"Kutyifa","sequence":"first","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stockburger","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Daubert","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Holmqvist","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Olshansky","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Schuger","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Klein","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brenyo","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McNitt","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Merkely","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Moss","sequence":"additional","affiliation":[{"name":"From the University of Rochester Medical Center, NY (V.K., H.K., I.G., A.B., S.M., W.Z., A.J.M.); Experimental and Clinical Research Center, a Joint Cooperation between the Charit\u00e9 Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (M.S.); Cardiology Department, Duke University, Durham, NC (J.P.D., F.H.); Department of Medicine, University of Iowa Health Care (B.O.); Henry Ford Hospital, Detroit, MI (C.S.); and Semmelweis University, Heart Center, Budapest, Hungary ..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032423"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050496"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013168"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906431"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009540"},{"key":"e_1_3_3_7_2","first-page":"543","article-title":"Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure.","volume":"17","author":"Zar\u0119ba W","year":"2010","unstructured":"Zar\u0119ba W. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure. Cardiol J. 2010;17:543\u2013548.","journal-title":"Cardiol J"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfp074"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2011.07.038"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2005.00073.x"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2012.00531.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2007.00770.x"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.960898"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2009.00309.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90588-R"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90769-U"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.24.3115"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2008.01106.x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr022"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-011-9338-3"}],"container-title":["Circulation: Arrhythmia and Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCEP.113.001299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:01:13Z","timestamp":1715558473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCEP.113.001299"}},"subtitle":["A Multicenter Automatic Defibrillator Implantation Trial\u2013Cardiac Resynchronization Therapy Substudy"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1161\/CIRCEP.113.001299"],"URL":"https:\/\/doi.org\/10.1161\/circep.113.001299","relation":{},"ISSN":["1941-3149","1941-3084"],"issn-type":[{"value":"1941-3149","type":"print"},{"value":"1941-3084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"2013-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}